pku-hc.comCrawled Nov 5, 2026
The updated 2026 edition of the *National Basic Drug Catalog*, jointly released by the National Health Commission, State Administration of Traditional Chinese Medicine, and National Center for Disease Control and Prevention, includes 794 drugs, an expansion from the 2018 version.
Peking University Pharmaceuticals Co., Ltd. (stock code: SZ.000788) is a core pharmaceutical member of the Founder Group’s medical and pharmaceutical industry—Beida Medical Industry Group—and has over 50 years of pharmaceutical manufacturing experience.
Orthopaedics tycoon Cheng Dong acquires PKU HealthCare (000788.SZ) through Shanghai Hongkang, buying 100% of its parent company, Southwest Synthetic Pharmaceutical Group, for US$0.14. The deal grants Cheng Dong control of the listed drugmaker, following an announcement on October 26. Cheng Dong is the chairman of Bon’er Orthopaedics, a private orthopaedics chain.
Oct 2026dealroom.coNews article
PKU HealthCare Corp., Ltd. reports a **50% decline in revenue** for the first nine months of 2026, with sales totaling **CNY 652.42 million**—down from **CNY 1.23 billion** in the same period the prior year. The earnings update covers the period ending **September 30, 2026**, reflecting a significant year-over-year contraction in financial performance.
Oct 2026MarketScreenerNews article
PKU HealthCare Corp., Ltd. announces its fiscal year 2025 earnings report will be released on **April 28, 2026**. The company provides healthcare services and pharmaceutical products across China. Investors and analysts track these updates to assess financial performance and strategic direction.
Dec 2025Simply Wall StNews article
PKU HEALTHCARE Co., Ltd. renames its subsidiary from *Beijing Peking University Medicine Co., Ltd.* to *Beijing New Advantage Pharmaceutical Commerce Co., Ltd.* The company also replaces legal representative Yuan Pingdong with Cheng Hong and completes industrial and commercial registration updates under China’s Market Supervision Administration. These changes align with strategic adjustments and business expansion plans.
Sep 2025LongbridgeNews article